Download the full report (130 p.)
Download the full report (130 p.)
Download the full report (130 p.)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
36 Hyperbaric Oxygenation Therapy KCE Reports 74<br />
3.4.15 Exceptional anaemia<br />
3.4.15.1 Short description of <strong>the</strong> condition<br />
Patients with an important loss of red blood cells through haemorrhage, haemolysis or<br />
aplasia, may experience suboptimal or even inadequate oxygen carrying capacity by <strong>the</strong><br />
blood.<br />
3.4.15.2 Summary of <strong>the</strong> evidence<br />
Where safely available as in Western Europe, <strong>the</strong> transfusion of red blood cells is <strong>the</strong><br />
most obvious answer to this problem. However, some people might refuse blood<br />
transfusions upon religious grounds, although this problem occurs less in Europe than<br />
for example in <strong>the</strong> US. Trust in <strong>the</strong> safety of locally obtained donor blood also might<br />
play an important role in <strong>the</strong> acceptance or refusal of patients to receive transfusions,<br />
but again this should be no problem in most European countries.<br />
Not surprisingly, <strong>the</strong> indication of exceptional anaemia is only accepted by UHMS in<br />
exceptional cases where <strong>the</strong> patient cannot receive or refuses to accept a transfusion, 8<br />
but this indication is not withheld by ECHM. 9 The evidence for this indication is mainly<br />
based on animal models and on small human case series and case <strong>report</strong>s. 8 A review of<br />
this observational evidence found generally positive results. 65<br />
3.4.16 Miscellaneous indications (not accepted by ECHM nor by UHMS)<br />
Acute Coronary<br />
Syndrome<br />
Apart from <strong>the</strong> above mentioned accepted indications by ECHM, UHMS or both, <strong>the</strong>re<br />
are numerous o<strong>the</strong>r indications, often based on little or no evidence.<br />
In Table 6 those indications that were covered by existing technology assessments or<br />
meta-analyses are shown and we indicate <strong>the</strong> most relevant references and a short<br />
summary of <strong>the</strong> main conclusions.<br />
Table 6. Miscellaneous indications for HBOT (only when treated in existing<br />
technology assessment or meta-analyses)<br />
Thesis: The Evidence Basis of Diving and Hyperbaric Medicine,<br />
chapter 13 1<br />
Cochrane review: Hyperbaric oxygen <strong>the</strong>rapy for acute coronary<br />
syndrome. 28<br />
Oxigenoterapia Hiperbárica: Utilidad Diagnóstica e Indicaciones<br />
(IECS 2006) 38<br />
Uses of Hyperbaric Oxygen Therapy (AHRQ 2006) 14<br />
Short summary of <strong>the</strong> evidence: very low quality evidence from very small trials for a lower risk of<br />
major adverse cardiac events and for a more rapid relieve from pain. No significant effect on<br />
mortality.<br />
Thesis: The Evidence Basis of Diving and Hyperbaric Medicine,<br />
chapter 15 1<br />
Cochrane review 2005: Hyperbaric oxygen <strong>the</strong>rapy for acute<br />
ischaemic stroke. 25<br />
Oxigenoterapia Hiperbárica: Utilidad Diagnóstica e Indicaciones<br />
(IECS 2006) 38<br />
Uses of Hyperbaric Oxygen Therapy (AHRQ 2006) 14<br />
Acute Ischemic Stroke<br />
Carson et al. 66<br />
Short summary of <strong>the</strong> evidence: no evidence for improved clinical outcomes when applied during <strong>the</strong><br />
acute presentation of ischemic stroke. Evidence from three RCTs is insufficient but clinical benefit<br />
does not seem likely.<br />
Acute Traumatic Brain<br />
Injury<br />
Thesis: The Evidence Basis of Diving and Hyperbaric Medicine,<br />
chapter 17 1<br />
Cochrane review 2004: Hyperbaric oxygen <strong>the</strong>rapy for <strong>the</strong> adjunctive<br />
treatment of traumatic brain injury. 33<br />
Oxigenoterapia Hiperbárica: Utilidad Diagnósticae Indicaciones (IECS<br />
2006) 38<br />
Uses of Hyperbaric Oxygen Therapy (AHRQ 2006) 14